The preferred method of testing for MVD is with PCR, antigen detection tests are less sensitive and specific. The treatment of MVD is supportive. Treatments which have shown promise in EVD, such as antibody therapies e.g. ZMAPP or the antiviral drug favipiravir, have not been clinically tested in humans with MVD.